CHESTER ALDRIDGE Chairma
Chairman & CEO
Chester Aldridge is the Founder, Chairman, and CEO of US Equity Holdings. Through US Equity Holdings, Chester incubates, finances, and manages numerous ventures across the artificial intelligence, entertainment, software, healthcare, renewable energy, basic materials, and transportation industries.
BACKGROUND
Chester brings over 25 years of experience in founding, scaling, and operating businesses ranging from start-ups to multi-million-dollar publicly traded companies. His career highlights include raising more than $300 million in early-stage private equity as a founder of multiple ventures; establishing collaborations with leading research and development institutions such as the Buck Institute for Research on Aging, NASA, and Fraunhofer; securing sales and distribution deals worth tens of millions of dollars with partners including Sony, Atari, and Vivendi Universal; and licensing major Hollywood properties, from Disney brands to Frank Miller’s Sin City and MTV’s Jackass.
HEALTHCARE
Chester is the Co-Founder and Chairman of Aelan Cell Technologies, a biotechnology company focused on the research, discovery, development, and commercialization of breakthrough biomedical technologies that promote human health and longevity. Founded in 2015 and headquartered in San Francisco, California, Aelan is guided by a world-class team of scientists and business leaders under the direction of Dr. Victoria Lunyak. The company has developed a robust intellectual property portfolio spanning both diagnostics and cell therapy and continues to forge strategic partnerships with organizations that share its mission of advancing and extending human life.
Chester was the Co-Founder and a member of the Board of Directors of Mount Tam Biotechnologies, a biopharmaceutical company formed on World Lupus Day in 2014. Mount Tam was established to develop, optimize, and commercialize breakthrough medical compounds that improve the health and well-being of people affected by autoimmune diseases. The company’s lead program focuses on a novel therapeutic for lupus.
Mount Tam Biotechnologies collaborates closely with the Buck Institute for Research on Aging, one of the world’s leading centers for biomedical innovation. Through an exclusive worldwide licensing and collaboration agreement with the Buck Institute, Mount Tam has access to the Institute’s most advanced R&D assets in the field of autoimmune disorders. This agreement includes TAM-01, a pre-IND stage compound representing a promising therapeutic candidate for systemic lupus erythematosus (SLE), the most common form of lupus, as well as additional early-stage compounds and a broad library of assets targeting autoimmune diseases.
The licensed portfolio is supported by an extensive intellectual property estate comprising more than 45 issued patents and patent applications worldwide, covering composition-of-matter, manufacturing, and therapeutic-area applications.
Chester has served, or currently serves, as a Strategic Advisor to the following companies:
Credence MedSystems is a pharma services and drug delivery company that has redefined how drug manufacturers commercialize injectable therapies through differentiated delivery systems. The company is an industry-recognized, award-winning innovator in injectable drug delivery devices for pharmaceutical and biotechnology manufacturers. Its broad portfolio of delivery platforms, protected by a robust intellectual property estate, addresses the evolving needs of the biopharmaceutical industry.
Credence’s flagship product, the Credence Companion® Safety Syringe System, has changed the paradigm for commercializing injectable drugs by enabling Innovation Without Change™: a differentiated safety delivery platform that enhances end-user safety while simplifying the path to commercialization for pharmaceutical partners. This strategy allows biopharma companies to deliver an improved user experience while minimizing implementation hurdles. Credence’s systems are built upon proven pre-filled syringes and components, enabling manufacturers to achieve marketable differentiation and cost-of-ownership advantages while preserving existing processes, sourcing preferences, and validated systems.
The company is led by a seasoned management team with deep experience in founding, leading, and scaling successful medical technology and drug delivery ventures. Credence MedSystems has received a strategic investment from Novartis, maintains strategic collaborations with SCHOTT AG, and has been awarded grants from the Bill & Melinda Gates Foundation, recognizing its innovation and contributions to global health.
Cure Holdings is a diversified healthcare and life sciences platform strategically positioned at the intersection of pharmaceutical innovation, advanced drug delivery technologies, compound manufacturing, and healthcare commercialization. The company is focused on developing and scaling next generation therapeutic solutions targeting some of the largest and fastest growing global healthcare markets, including obesity management, diabetes, vaccines, specialty pharmaceuticals, nutraceuticals, and precision healthcare. Through its integrated operating model spanning research and development, compound pharmacy operations, and pharmaceutical licensing, Cure Holdings is building a scalable healthcare ecosystem designed to improve patient outcomes, enhance treatment accessibility, and accelerate commercialization across multiple high value therapeutic sectors.
At the core of the company’s platform is its proprietary patent protected oral thin film delivery technology, designed to improve bioavailability, patient compliance, convenience, and therapeutic efficiency while bypassing many of the limitations associated with traditional pills and injectable therapies. The company’s advanced delivery systems are being developed for applications including GLP-1 weight management therapies, insulin delivery, vaccines, erectile dysfunction treatments, and specialty pharmaceutical products. Cure Holdings is strategically targeting the rapidly expanding obesity and metabolic health sector, where global GLP-1 and obesity related markets are projected by many analysts to exceed $100 billion annually within the coming years as demand for next generation weight management therapies accelerates worldwide.
Cure Holdings’ technology platform is designed to address major healthcare challenges including patient non adherence, needle avoidance, refrigeration logistics, poor oral bioavailability, and limited healthcare access in underserved regions. By combining advanced pharmaceutical formulation technologies, intellectual property development, compound manufacturing capabilities, and strategic licensing initiatives, the company is positioning itself to participate across multiple segments of the pharmaceutical value chain while building a diversified portfolio of scalable healthcare assets.
Driven by innovation, commercialization, and long term healthcare transformation, Cure Holdings is focused on creating differentiated pharmaceutical and healthcare solutions capable of addressing massive global market opportunities while advancing more convenient, efficient, and patient friendly treatment options for millions of people worldwide.
Prosetta Biosciences is a San Francisco–based biotechnology company developing innovative therapeutics for a broad range of diseases. The company’s research focuses on discovering and advancing novel small molecules that modulate the assembly of multi-protein complexes within cells.
The Prosetta Platform has been successfully applied to both infectious and degenerative diseases, representing a transformative approach to medicine. Unlike most conventional drugs, Prosetta’s assembly modulators work in concert with the body’s own regulatory mechanisms, providing a novel strategy for restoring molecular homeostasis and addressing disease at its source.
Akonni Biosystems, based in Frederick, Maryland, is a molecular diagnostics (MDx) company that develops, manufactures, and markets fully integrated molecular diagnostic systems. Strategically located near Fort Detrick, the National Institutes of Health (NIH), and the National Cancer Institute (NCI), Akonni operates a state-of-the-art, 20,000-square-foot manufacturing facility dedicated to advancing molecular testing technologies and improving global healthcare outcomes.
PuraCath Medical is dedicated to improving the speed and efficacy of catheter connection disinfection, enhancing quality of life for both patients and healthcare providers. The company’s novel, easy-to-use technology helps keep patients healthy and protected from infection while reducing dependence on user compliance. PuraCath Medical aims to become a global leader in connection disinfection technology and to establish a new standard of care in infection prevention.
FINANCE
Chester serves as a trusted Strategic Advisor and Partner to one of Canada’s largest family offices, where he guides investment strategy, sources and evaluates opportunities, and executes across private equity, venture capital, real estate, and alternative assets. His work focuses on aligning capital deployment with the family’s values and long-term objectives, ensuring that each investment supports sustainable growth and multi-generational wealth preservation.
ARTIFICIAL INTELLIGENCE (AI)
Chester is the Founder, Chairman, and CEO of Pytharion Labs, an advanced artificial intelligence company focused on the development of next generation cognitive computing, associative intelligence, and highly scalable AI infrastructure technologies designed to address some of the most important challenges in modern artificial intelligence. The company is focused on building breakthrough AI architectures intended to advance reliability, reasoning, explainability, efficiency, and adaptive intelligence across enterprise, government, defense, healthcare, scientific, and large scale industrial applications.
Pytharion Labs is developing proprietary AI technologies designed to move beyond the limitations of traditional large language model architectures by emphasizing more deterministic intelligence systems, composable reasoning, low data learning capabilities, scalable cognitive frameworks, and advanced symbolic and associative processing. The company’s long term vision centers on creating AI systems capable of operating with greater transparency, lower hallucination rates, improved decision consistency, enhanced contextual understanding, and significantly reduced computational and training inefficiencies compared to conventional AI models.
The company is positioning itself at the forefront of next generation artificial intelligence innovation, with a strategic focus on high value markets where trust, explainability, security, low latency, and mission critical decision making are essential. Its technology initiatives are aimed at enabling transformative applications across defense intelligence, autonomous systems, enterprise AI infrastructure, scientific research, edge computing, advanced analytics, and other sectors where highly reliable cognitive systems represent a major strategic advantage.
By combining advanced AI research, scalable software architecture, cognitive systems engineering, and long term platform development strategies, Pytharion Labs is pursuing the creation of foundational artificial intelligence technologies designed to support the next evolution of intelligent computing on a global scale.
Chester served as Chief Evangelist for DataShapes AI, an advanced artificial intelligence company originally developed within an incubator funded by renowned entrepreneur and venture capitalist Carl Berg, who has appeared multiple times on Forbes’ list of the 400 richest Americans. The platform was developed through more than a decade of research and over $18 million in investment, with Carl Berg’s venture firm later leading an additional $5 million commercialization investment.
DataShapes AI is led by an accomplished executive and advisory team that includes Peter D. Kiernan III, Executive Chairman of DataShapes AI, former Goldman Sachs Partner, former President of Cyrus Capital, CEO of Kiernan Ventures, and former Chairman of the Robin Hood Foundation.
Built by experts in cyber, signals intelligence, and artificial intelligence, the DataShapes AI team has created and patented first-in-class AI technology that automates radio frequency intelligence, enabling warfighters to control the battle of the spectrum across highly complex operational environments. The platform delivers extraordinarily efficient self-learning capabilities and highly accurate spectrum intelligence within a versatile, serverless, low-SWaP-C architecture designed for next-generation defense, intelligence, and national security applications.
Chester serves on the Board of Directors of Hjarna, an AI-powered healthcare platform focused on the early detection and monitoring of cognitive impairment through conversational speech analysis and advanced machine learning. The company’s technology autonomously engages patients through simple telephone-based conversations, analyzes speech and behavioral biomarkers using proprietary AI algorithms, and delivers cognitive risk assessments to healthcare providers to support earlier intervention and improved patient outcomes. Designed to make proactive brain health screening as routine and accessible as traditional preventative healthcare, Hjarna combines conversational AI, predictive analytics, and scalable cloud-based infrastructure to address the rapidly growing global demand for neurological and cognitive health solutions. The platform is supported by proprietary intellectual property, multiple patent filings spanning software, wearable, and multimodal diagnostic pathways, and a long term roadmap expanding into continuous brain health monitoring, cognitive training, and direct-to-consumer AI health applications.
TECHNOLOGY
Chester was Executive Chairman and Co-Founder of PV Tech Group, a company that provided a comprehensive range of services to photovoltaic (PV) manufacturers, including full-scale integration of PV manufacturing facilities spanning wafers, cells, and modules as well as strategic planning, technical evaluation, process optimization, and project management.
With deep expertise in PV process technology, manufacturing equipment, and operational infrastructure, the PV Tech Group team had designed and installed advanced systems across the globe, including in Greece, Russia, Spain, and North America. The company’s clients included CH2M Hill, King Abdulaziz City for Science and Technology (KACST), TransCanada, and GT Advanced Technologies.
Chester was a Founding Sponsor of the Fraunhofer TechBridge Program, operated by the Fraunhofer Center for Sustainable Energy Systems (Fraunhofer CSE) in Cambridge, Massachusetts. Fraunhofer, Europe’s largest application-oriented research organization, works in close collaboration with leading scientists at the Massachusetts Institute of Technology (MIT) to advance innovation in clean energy technologies.
The TechBridge Program was established by Fraunhofer CSE to accelerate the development and commercialization of innovative clean technologies. TechBridge provides an open innovation and technology validation platform for investors and industry sponsors, helping to identify and de-risk promising technologies by leveraging the extensive resources of Fraunhofer CSE, the greater Fraunhofer network, and the Fraunhofer Energy Alliance. Through this collaborative approach, the program bridges the gap between scientific research and commercial deployment supporting breakthrough clean energy ventures and driving sustainable innovation.
The Fraunhofer-Gesellschaft is one of the world’s most powerful and respected applied research organizations and the largest application-oriented research institution in Europe. Founded in Germany in 1949, Fraunhofer operates more than 75 elite research institutes with nearly 32,000 scientists, engineers, and technology professionals advancing breakthrough innovation across artificial intelligence, semiconductors, quantum systems, advanced manufacturing, energy, cybersecurity, aerospace, and biotechnology. With an annual research budget exceeding €3.6 billion and deep partnerships with global industry leaders, government agencies, and top research institutions, Fraunhofer is internationally recognized as a major engine of scientific commercialization, industrial innovation, and next-generation technology development.
ENERGY
Chester Aldridge is the Chief Advisor to Brillouin Energy, where he plays a pivotal role in guiding the company’s strategic direction and commercialization of its breakthrough Low Energy Nuclear Reactions (LENR) technology. After closely tracking the company’s progress for over a decade, Chester became actively involved following key third-party validations, including independent work conducted by SRI International. He was instrumental in helping assemble a world-class leadership team to transition the company from advanced research into pilot manufacturing and early commercialization.
Brillouin Energy’s technology was advanced over more than 15 years of dedicated laboratory research in Berkeley, California, supported by third-party technical resources, external vendors, and a network of early advocates and technology leaders, including Carl Page, entrepreneur and brother of Larry Page. With its Hydrogen Hot Tube (HHT) and proprietary Q-Pulse control system, the company is pursuing a safe, ultra-clean, zero-emission heat source designed for industrial and distributed energy applications. The company’s pilot manufacturing and development operations are now headquartered in Emeryville, California, within a 37,000+ square foot facility supporting accelerated scale-up and commercialization. Chester has helped strengthen the company’s commercialization strategy, leadership structure, and long-term positioning as it moves toward scalable market deployment.
Under this foundation, Brillouin attracted major backing from Tim Mellon, who completed the Series C Preferred Round, initiated the Series D Preferred Round as lead investor, and contributed 36 acres of industrially zoned land in Connecticut to support the company’s next phase of development. Chester’s work bridges breakthrough science, strategic execution, and investor confidence, positioning Brillouin Energy as a serious contender in what could become one of the most significant energy breakthroughs of the century.
BASIC MATERIALS
Chester is the founding investor in Neroshield, an advanced specialty chemicals and fire protection technology company focused on developing next generation environmentally responsible fire retardant systems, advanced protective materials, and industrial safety solutions for infrastructure, defense, transportation, energy, and high risk industrial applications.
Neroshield develops high performance specialty chemistry technologies engineered to improve fire resistance, reduce ignition risk, slow flame propagation, and enhance material protection across a broad range of commercial and industrial environments. The company’s platform is focused on delivering sustainable, high performance alternatives to traditional fire retardant systems while addressing the growing global demand for wildfire mitigation, resilient infrastructure, advanced industrial safety, and environmentally responsible protective materials.
Positioned at the intersection of advanced materials science, specialty chemicals, and industrial safety technologies, Neroshield operates within one of the fastest growing segments of the global protective materials market as industries and governments increasingly prioritize fire resilience, infrastructure protection, sustainability, and next generation safety technologies.
Chester was the Co-Founder, Chairman, and CEO of Equity Solar, a company dedicated to advancing photovoltaic technology through innovative material science. Equity Solar developed proprietary chemistries that enhanced the efficiency of photovoltaic (PV) cells, helping manufacturers increase energy output and reduce cost per watt through advanced silicon surface solutions.
The company’s licensed technology originated from a collaboration with NASA’s Glenn Research Center and introduced a novel process for growing silicon oxide at room temperature. The technology received research grants from both the Department of Defense and NASA and was highlighted in NASA’s annual publication showcasing significant scientific contributions.
Equity Solar partnered with leading chemical companies including DuPont, Heraeus, Honeywell, and BASF, as well as major global PV cell manufacturers such as Hareon, Astronergy, Canadian Solar, ReneSola, Suntech, CSUN, JA Solar, ET Solar, Yingli Solar, SRPV, DMEGC, M Cells, Juli New Energy, Lightway, and Hanwha. The company also partnered with Fraunhofer CSE for technology validation.
In recognition of its technological innovation and impact on the solar industry, Equity Solar received the prestigious SNEC Gold Award.
ENVIRONMENTAL CONSERVATION
Chester served as a Strategic Advisor to the Fraunhofer-Gesellschaft and its Fraunhofer Institute for Building Physics (IBP) on the Pompeii Sustainable Preservation Project (PSPP) at the Archaeological Park of Pompeii. The international initiative combines science, engineering, and cultural heritage research to develop advanced conservation materials, digital monitoring systems, and preventive preservation strategies ensuring the long-term protection of this UNESCO World Heritage Site.
ENTERTAINMENT
Chester has built substantial ventures across the entertainment industry, spanning music, video games, toys and board games, as well as sports.
Music
Chester is the Personal Manager to Walter Afanasieff, one of the most accomplished and commercially successful music producers, songwriters, and arrangers in modern entertainment history. A multi Grammy Award winning producer and former Grammy “Producer of the Year” recipient, Walter has helped create some of the biggest records and most iconic songs ever produced, with projects collectively generating hundreds of millions of albums sold worldwide, countless multi platinum and gold certifications, and decades of global chart dominance.
Widely regarded as one of the defining architects of contemporary pop music, Walter has worked with an extraordinary roster of legendary artists including Mariah Carey, Celine Dion, Whitney Houston, Barbra Streisand, Lionel Richie, Josh Groban, Andrea Bocelli, Michael Bolton, Ricky Martin, Christina Aguilera, Luther Vandross, Kenny G, Babyface, Toni Braxton, Destiny’s Child, Michael Jackson, Stevie Wonder, John Legend, Billy Joel, and John Mayer, among many other globally recognized superstars.
Walter is best known for producing My Heart Will Go On, the Academy Award winning theme song from Titanic and one of the best selling singles in music history, which earned him the Grammy Award for Record of the Year. He also co-wrote and produced numerous global number one hits with Mariah Carey including Hero, One Sweet Day, and All I Want for Christmas Is You, one of the most successful and enduring holiday songs ever recorded. Walter additionally produced major soundtrack hits for Disney including A Whole New World from Aladdin, along with music from Beauty and the Beast, Hercules, and The Hunchback of Notre Dame, solidifying his legacy as one of the most influential hitmakers in the history of the global music industry.
Chester is the Co-Founder of Noisecastle III, a music production house that has exclusively licensed the entertainment rights to composer and producer Scott Bruzenak. Scott has worked with artists including JoJo, Dawn Richard and Diplo’s Los Angeles-based record label Mad Decent’s artist-Liz, who has been featured in Pitchfork, Vice, and Billboard. As a producer and songwriter, Scott has also worked alongside Babyface, Rodney Jerkins, Walter Afanasieff and Rob Cavallo. One of Scott's highlights includes producing and co-writing Daya’s double-platinum singles "Hide Away" and “Sit Still, Look Pretty”.
Chester exclusively licensed the entertainment rights to Austin Brown, the nephew of Michael Jackson. Austin has worked with Grammy Award winning Producer and Co-writer Rodney Jerkins and Walter Afanasieff, and recording artists Pharrell Williams and Q-Tip.
Chester has acted as an advisor to record producer, songwriter and musician Rodney Jerkins. A recipient of four Grammy Awards, Rodney has produced for Michael and Janet Jackson, Beyoncé, Kanye West, Katy Perry, Lindsay Lohan, Lionel Richie, Mary J. Blige, Jennifer Lopez,Whitney Houston, Cher, Lady Gaga, Will Smith, Aaliyah, Brandy Norwood, Monica, Britney Spears, The Black Eyed Peas, Keyshia Cole, Toni Braxton, Natasha Bedingfield, Jessica Simpson, Brian McKnight, Tamia, Utada Hikaru, Wonder Girls, JYJ, LMFAO, PLATINUM, Pussycat Dolls, Destiny’s Child, the Spice Girls, Danity Kane, TLC, and The Saturdays.
Toy & Board Games
Chester invented, patented, published, and created Stealth Chess, an award-winning strategy game that was named one of Games Magazine’s Top 100 Games and honored as a Mensa Select Award winner for innovation and design excellence.
Chester also invented, patented, and published The Deck of Dice, a deck-of-cards game that simulates dice rolls and has been featured in international tournaments for The Settlers of Catan as well as in casino resorts across the United States. He also invented, patented, and published Megatak: The Electronic Prankster, an award winning electronic handheld toy.
Video Games
Chester founded and led a private video game development studio that created software and art for several iconic titles. His company contributed to the acclaimed Reader Rabbit educational software series including Kindergarten, 1st Grade, 2nd Grade, and 6th Grade programs as well as major Electronic Arts franchises such as The Sims, The Sims: House Party Expansion Pack, The Sims: Deluxe Edition, and SimCity 3000 Unlimited.
Chester founded a publicly traded video game publishing company that licensed and released a portfolio of acclaimed titles, including MTV’s Jackass, Frank Miller’s Sin City, Crusty Demons, Heroes of the Pacific, Lucinda Green’s Equestrian Challenge, and GripShift. He assembled a world-class management team that included the President of Disney Software, the CFO of Activision, and the President of Electronic Arts, bringing deep industry leadership and expertise to the company. Chester’s firm also served as the exclusive distributor for Pocket PC and Palm games for EA Sports and Electronic Arts, featuring top franchises such as Tiger Woods PGA Tour Golf, FIFA Soccer 2002, SimCity 2000: The Ultimate City Simulator, and Ultima Underground: The Stygian Abyss. For more details, visit Chester’s IMDb profile.
Sports
Chester is the Co-Founder of Zone Motion alongside former Kansas City Royals shortstop and 1985 World Series Champion Buddy Biancalana. Zone Motion delivers cutting-edge mental performance and peak-state training for elite athletes. Buddy has implemented his Zone Motion Training System with numerous high-profile athletes, including Shane Baz, Scott McCarron, Charlie Hoffman, Adam Ottavino, Austin Davis, Jeremy Affeldt, Matt Cain, and MLB Hall of Famer George Brett.
Chester has served as a strategic advisor to Dallas Cowboys legend and Hall of Famer Tony Dorsett, the Heisman Trophy winner and Super Bowl champion widely regarded as one of the greatest running backs in NFL history.
Tourism
Chester is an owner of Sail Maui, one of Hawaii’s premier luxury sailing and ocean adventure companies and widely recognized as Maui’s fastest high performance catamaran operator. Originally established in 1994, Sail Maui has built an elite reputation for delivering world class sailing experiences across the Hawaiian Islands, including luxury snorkeling excursions, sunset sails, whale watching adventures, destination cruises, and exclusive private charters aboard its fleet of high performance catamarans. The company owns and operates multiple custom sailing vessels, with several of its catamarans sailing from historic Lahaina, one of Maui’s most iconic and internationally recognized oceanfront destinations. Led by an award winning team of captains and professional sailors, Sail Maui combines authentic Hawaiian hospitality with cutting edge performance sailing to create one of the most respected ocean tourism brands in the Pacific. Over more than two decades, the company has hosted thousands of guests from around the world and has consistently been recognized for excellence in customer experience, safety, and service. Sail Maui has earned TripAdvisor’s prestigious Travelers’ Choice Award and ranks among the top 10% of attractions worldwide, solidifying its position as one of the most recognized and highly rated catamaran experiences in Hawaii. For more information please visit Sail Maui’s website.
Chester is an Owner of Maui Concierge Service (MCS), a premier luxury hospitality and guest experience management company operating concierge and resort service programs across some of the most exclusive resort destinations in Hawaii. The company specializes in delivering high touch guest engagement and premium hospitality solutions including lobby concierge services, beach and poolside concierge and retail operations, resort photography, VIP and group guest coordination, activity and excursion planning, and advanced virtual concierge support. With operations spanning nine premier resorts on Maui and an additional luxury resort on the Big Island, MCS has established itself as a trusted hospitality partner within Hawaii’s high end tourism and resort industry, serving thousands of guests from around the world each year.
MCS supports an elite portfolio of luxury resort properties including Hyatt Vacation Club at Ka’anapali, Ka’anapali Ali’i Resort, The Whaler on Ka’anapali Beach, Napili Kai Beach Resort, Wailea Beach Villas, CoralTree Residence Collection Wailea, and CoralTree Residence Collection Big Island. Through its deep operational expertise, long standing resort relationships, and commitment to exceptional guest service, Maui Concierge Service has become one of Hawaii’s leading providers of luxury concierge and resort guest experience solutions within the world class Hawaiian hospitality market. For more information please visit Maui Concierge Service’s website.
Chester is an Owner of Drift Coffee, a Lahaina-based premium coffee and catering company known for its commitment to quality, community, and authentic Hawaiian hospitality. The company is temporarily closed due to the devastating Lahaina fire, with plans to rebuild and reopen in support of the local community’s recovery and resilience.
MEMBERSHIPS
Chester is a Life Member of the Stanford Graduate School of Business Alumni Association and an active member of the Stanford Club of Marin.
Chester continues his executive education through online coursework with Harvard Business School and was recently recognized for completing the Negotiation Mastery program.
Chester was a Founding Sponsor of the Fraunhofer TechBridge Program.
Chester was formerly a member of the Buck Advisory Council (BAC), a committee composed of distinguished leaders from around the world representing government, business, pharmaceuticals, law, and other key sectors. As a BAC member, Chester served as an Ambassador to the Buck Institute for Research on Aging, the nation’s first independent research facility dedicated exclusively to understanding the connection between aging and chronic disease.
Chester is a USA Weightlifting Certified Coach, a certification recognized as the gold standard for strength and performance coaching in the United States. Through this affiliation with USA Weightlifting, the official governing body for Olympic weightlifting, Chester reflects his commitment to physical performance, discipline, and athlete development.
